Qube Research & Technologies (QRT)’s Global Cord Blood Corporation CO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CO Stock Details CO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-448,755	Closed	-$1.73M	–	3366
2022 Q1	$1.73M	Hold	448,755	–	–	0.01%	874
2021 Q4	$1.88M	Buy	448,755 +253,949	+130%	+$1.08M	0.01%	879
2021 Q3	$910K	Buy	194,806 +15,314	+9%	+$75.1K	0.01%	944
2021 Q2	$958K	Buy	179,492 +85,061	+90%	+$445K	0.01%	960
2021 Q1	$428K	Buy	+94,431	New	+$410K	0.01%	1272

Other funds holding CO

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

BCM

BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CO Position: Q2 2022 in Review

Qube Research & Technologies (QRT) sold out of Global Cord Blood Corporation (CO) in Q2 2022, closing a stake of 448,755 shares — an estimated $1.73M sold.

Qube Research & Technologies (QRT) first reported a position in CO in Q1 2021 and held it in 5 quarters. The position peaked at $1.88M in Q4 2021. 25 funds tracked by Wall St. Rank hold CO as of Q2 2022.

Qube Research & Technologies (QRT) reported no remaining Global Cord Blood Corporation position as of Q2 2022 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 448,755 Global Cord Blood Corporation shares in Q2 2022, an estimated $1.73M.
Qube Research & Technologies (QRT) first reported a position in Global Cord Blood Corporation in Q1 2021 and held it in 5 quarters.
Qube Research & Technologies (QRT)'s Global Cord Blood Corporation position peaked at $1.88M in Q4 2021.
25 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2022, filed 15 Aug 2022.